Ramesh K Khurana1. 1. Department of Medicine, MedStar Union Memorial Hospital, 201 East University Parkway, Baltimore, MD, 21218, USA, ramesh.khurana@medstar.net.
Abstract
OBJECTIVE: Both psychogenicity and organicity have been asserted in postural tachycardia syndrome (PoTS). We studied the genesis of palpitations to dissect the biologic nature of PoTS. METHODS: Eleven PoTS patients and 10 control subjects were asked to discriminate types of palpitations when supine and in response to two sympathetic stimuli [Valsalva maneuver (VM) and 10-min head-up tilt (HUT)] and one vagolytic stimulus (atropine administration). Participants rated the 10 items of the somatosensory amplification scale to assess symptom exaggeration. Their time-dependent heartbeat counts were compared against EKG data to study ability to perceive heartbeat. RESULTS: Maximal heart rate increase (mean ± SE) over baseline (bpm) did not differ statistically between patients and controls (VM, 39.3 ± 4.7 versus 28.9 ± 3.9, respectively; p = 0.11; HUT, 42.4 ± 4.2 versus 34.7 ± 2.6, respectively; p = 0.14; and atropine, 47.8 ± 2.5 versus 52.0 ± 2.1, respectively; p = 0.22). Palpitations were more frequent in patients at baseline (55 versus 0 %, p = 0.006) and with VM (82 versus 10 %, p = 0.001) and HUT (64 versus 0 %, p = 0.002), but not with atropine (64 versus 60 %, respectively; p = 0.86). Patients discriminated more types of palpitations than did controls (seven versus three types). No difference was observed in somatosensory amplification or heartbeat perception. INTERPRETATION: Palpitations were independent of tachycardia and were predominantly sympathetically mediated. The lack of somatosensory amplification militated against psychogenicity. PoTS patients were not superior in detecting peripheral cardiac sensation. However, patients were superior in discriminating palpitations qualitatively in response to individual stimuli, suggesting central visceral sensitization. Explanation of the nature of symptoms and pharmacologic management may be of therapeutic benefit.
OBJECTIVE: Both psychogenicity and organicity have been asserted in postural tachycardia syndrome (PoTS). We studied the genesis of palpitations to dissect the biologic nature of PoTS. METHODS: Eleven PoTS patients and 10 control subjects were asked to discriminate types of palpitations when supine and in response to two sympathetic stimuli [Valsalva maneuver (VM) and 10-min head-up tilt (HUT)] and one vagolytic stimulus (atropine administration). Participants rated the 10 items of the somatosensory amplification scale to assess symptom exaggeration. Their time-dependent heartbeat counts were compared against EKG data to study ability to perceive heartbeat. RESULTS: Maximal heart rate increase (mean ± SE) over baseline (bpm) did not differ statistically between patients and controls (VM, 39.3 ± 4.7 versus 28.9 ± 3.9, respectively; p = 0.11; HUT, 42.4 ± 4.2 versus 34.7 ± 2.6, respectively; p = 0.14; and atropine, 47.8 ± 2.5 versus 52.0 ± 2.1, respectively; p = 0.22). Palpitations were more frequent in patients at baseline (55 versus 0 %, p = 0.006) and with VM (82 versus 10 %, p = 0.001) and HUT (64 versus 0 %, p = 0.002), but not with atropine (64 versus 60 %, respectively; p = 0.86). Patients discriminated more types of palpitations than did controls (seven versus three types). No difference was observed in somatosensory amplification or heartbeat perception. INTERPRETATION: Palpitations were independent of tachycardia and were predominantly sympathetically mediated. The lack of somatosensory amplification militated against psychogenicity. PoTS patients were not superior in detecting peripheral cardiac sensation. However, patients were superior in discriminating palpitations qualitatively in response to individual stimuli, suggesting central visceral sensitization. Explanation of the nature of symptoms and pharmacologic management may be of therapeutic benefit.
Authors: Christopher J Mathias; David A Low; Valeria Iodice; Andrew P Owens; Mojca Kirbis; Rodney Grahame Journal: Nat Rev Neurol Date: 2011-12-06 Impact factor: 42.937
Authors: Donald D Price; Jason G Craggs; QiQi Zhou; G Nicholas Verne; William M Perlstein; Michael E Robinson Journal: Neuroimage Date: 2009-04-16 Impact factor: 6.556
Authors: Satish R Raj; Bonnie K Black; Italo Biaggioni; Sachin Y Paranjape; Maricelle Ramirez; William D Dupont; David Robertson Journal: Circulation Date: 2009-08-17 Impact factor: 29.690
Authors: Lisa M Benrud-Larson; Paola Sandroni; Jennifer A Haythornthwaite; Teresa A Rummans; Phillip A Low Journal: Health Psychol Date: 2003-11 Impact factor: 4.267